Clinical assessment and identification of immuno-oncology markers concerning the 19-gene based risk classifier in stage IV colorectal cancer

BACKGROUND: Genomic profiling of tumors has contributed to the understanding of colorectal cancer (CRC), facilitating diagnosis, prognosis and selection of treatments, including targeted regimens. A report suggested that a 19-gene-based risk classifier (TCA19) was a prognostic tool for patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Jong Lyul, Roh, Seon Ae, Kim, Chan Wook, Kwon, Yi Hong, Ha, Ye Jin, Kim, Seon-Kyu, Kim, Seon-Young, Cho, Dong-Hyung, Kim, Yong Sung, Kim, Jin Cheon
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Baishideng Publishing Group Inc 2019
Materias:
Basic Study
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429345/
https://www.ncbi.nlm.nih.gov/pubmed/30918427
http://dx.doi.org/10.3748/wjg.v25.i11.1341

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6429345/
https://www.ncbi.nlm.nih.gov/pubmed/30918427
http://dx.doi.org/10.3748/wjg.v25.i11.1341

Ejemplares similares